Srilaxmi Kalavalapalli,
Medical Scientist IV; Manager, Endocrinology & Diabetes Research Laboratory
Department:
MD-ENDOCRINOLOGY
Business Phone:
(352) 273-8490
Business Email:
srilaxmi.kalavalapalli@medicine.ufl.edu
Publications
Academic Articles
2024
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants.
JHEP reports : innovation in hepatology.
6(7)
[DOI] 10.1016/j.jhepr.2024.101092.
[PMID] 39022386.
2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen.
Obesity (Silver Spring, Md.).
32(10):1967-1974
[DOI] 10.1002/oby.24130.
[PMID] 39315409.
2023
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
The Journal of clinical endocrinology and metabolism.
108(5):1192-1201
[DOI] 10.1210/clinem/dgac660.
[PMID] 36378995.
2023
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.
Diabetes, obesity & metabolism.
25(4):1112-1116
[DOI] 10.1111/dom.14936.
[PMID] 36495442.
2022
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients.
Metabolism and target organ damage.
2
[DOI] 10.20517/mtod.2022.08.
[PMID] 36017449.
2021
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
Diabetes care.
44(2):399-406
[DOI] 10.2337/dc20-1997.
[PMID] 33355256.
2021
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
The Journal of clinical endocrinology and metabolism.
106(11):e4360-e4371
[DOI] 10.1210/clinem/dgab417.
[PMID] 34190318.
2021
Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
PloS one.
16(6)
[DOI] 10.1371/journal.pone.0251449.
[PMID] 34077443.
2020
Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
68(3):743-747
[DOI] 10.1136/jim-2019-001186.
[PMID] 31852748.
2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Metabolism: clinical and experimental.
110
[DOI] 10.1016/j.metabol.2020.154297.
[PMID] 32562798.
2019
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
Diabetes, obesity & metabolism.
21(4):812-821
[DOI] 10.1111/dom.13584.
[PMID] 30447037.
2019
Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
The Journal of endocrinology.
241(3):293-305
[DOI] 10.1530/JOE-19-0007.
[PMID] 31082799.
2019
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
The Journal of clinical endocrinology and metabolism.
104(8):3327-3336
[DOI] 10.1210/jc.2018-02414.
[PMID] 30848827.
2019
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Diabetes care.
42(8):1481-1488
[DOI] 10.2337/dc19-0167.
[PMID] 31332029.
2019
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes.
Diabetes care.
42(7):1348-1351
[DOI] 10.2337/dc18-2578.
[PMID] 31221701.
2018
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
Diabetes care.
41(1):187-192
[DOI] 10.2337/dc17-1349.
[PMID] 29133343.
2018
Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.
American journal of physiology. Endocrinology and metabolism.
315(2):E163-E173
[DOI] 10.1152/ajpendo.00023.2018.
[PMID] 29634314.
2018
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
16(4):558-566.e2
[DOI] 10.1016/j.cgh.2017.12.001.
[PMID] 29223443.
2018
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Diabetes, obesity & metabolism.
20(7):1702-1709
[DOI] 10.1111/dom.13285.
[PMID] 29527789.
2017
Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis.
Alimentary pharmacology & therapeutics.
46(1):56-61
[DOI] 10.1111/apt.14111.
[PMID] 28470881.
2017
Corrigendum: Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.
Nature communications.
8
[DOI] 10.1038/ncomms16143.
[PMID] 31305776.
2017
Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease
Metabolomics.
[DOI] 10.1007/s11306-017-1280-1.
2017
Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.
Nature communications.
8
[DOI] 10.1038/ncomms14477.
[PMID] 28205519.
2016
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
American journal of physiology. Endocrinology and metabolism.
310(7):E484-94
[DOI] 10.1152/ajpendo.00492.2015.
[PMID] 26814015.
2016
Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
64(1):63-8
[DOI] 10.1136/jim-2015-000019.
[PMID] 26755815.
2015
Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
American journal of physiology. Endocrinology and metabolism.
309(4):E311-9
[DOI] 10.1152/ajpendo.00161.2015.
[PMID] 26058864.
2015
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
PloS one.
10(11)
[DOI] 10.1371/journal.pone.0139663.
[PMID] 26599546.
Grants
Dec 2023
ACTIVE
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus
Role: Other
Funding: BOEHRINGER INGELHEIM PHARM INC
Contact Details
Phones:
- Business:
- (352) 273-8490
Emails:
- Business:
- srilaxmi.kalavalapalli@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100226
GAINESVILLE FL 32610 - Business Street:
-
1600 SW ARCHER RD
GAINESVILLE FL 32610